Slow progression of periampullary neoplasia in familial adenomatous polyposis

Journal of Gastrointestinal Surgery

Volumn 6, Issue 6, 2002, Pages 831-837

  Moozar, Kouros L ^a   Madlensky, Lisa ^a   Berk, Terri ^a   Gallinger, Steven ^a   Aranha, G V ^b   Pitt, H A ^b   Matthews, J B ^b   Sugerman, H J ^b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b Mount Sinai Hospital ^*

Author keywords

Duodenal polyps; Familial adenomatous polyposis; Periampullary polyps

Indexed keywords

ADENOMATOUS POLYP; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ANALYTIC METHOD; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DUODENUM; DUODENUM TUMOR; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SURGEON; CANADA; COLON POLYPOSIS; COLONOSCOPY; COMPARATIVE STUDY; DISEASE COURSE; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; INCIDENCE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; MONITORING; NEEDLE BIOPSY; PROGNOSIS; PROSPECTIVE STUDY; SEX RATIO;

ADENOMATOUS POLYPOSIS COLI; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; COLONOSCOPY; DISEASE PROGRESSION; DUODENAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MASS SCREENING; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEOPLASM STAGING; ONTARIO; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX DISTRIBUTION;

EID: 15944397552     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(02)00062-8     Document Type: Article

References (30)

1. Griffioen G, Bus PJ, Vasen HFA, Verspaget HW, Lamers CB. Extracolonic manifestations of familial adenomatous polyposis: Desmoid tumors, and upper gastrointestinal adenomas and carcinomas. Scand J Gastroenterol 1998;33 (Suppl)225:85-91.
2. Offerhaus GJA, Entlus MM, Giardiello FM. Upper gastrointestinal polyps in familial adenomatous polyposis. Hepatogastroenterology 1999;46:667-669.
3. Spigelman AD. Screening modalities in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer. Gastrointest Endosc Clin North Am 1997;81-86.
4. Belchetz LA, Berk T, Bapat BV, Cohen Z, Gallinger S. Changing causes of mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 1996;39:384-387.
5. Galle TS, Juel K, Bulow S. Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 1999;34:808-812.
6. Wallace MH, Phillips RK. Upper gastrointestinal disease in patients with familial adenomatous polyposis. Br J Surg 1998;85:742-750.
7. Norton ID, Gostout CJ. Management of periampullary adenomas. Dig Dis 1998;16:266-273.
8. Sanabria JR, Croxford R, Berk T, Cohen Z, Bapat BV, Gallinger S. Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. Am J Surg 1996;171:136-141.
9. Nugent KP, Spigehnan AD, Phillips RKS. Risk of extracolonic cancer in familial adenomatous polyposis. Br J Surg 1996;83:1121-1122.
10. Jagleman DG, DeCosse JJ, Bussey HJR, and The Leeds Castle Polyposis Group. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988;8595:1149-1150.
11. Nugent KP, Spigelman AD, Williams CB, Talbot IC, Phillips KS. Surveillance of duodenal polyps in familial adenomatous polyposis: Progress report. J R Soc Med 1994;87:704-706.
12. Spigelman AD, Talbot IC, Penna C, Nugent KP, Phillips RK, Costello C, DeCosse JJ. Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. J Clin Pathol 1994;47:709-710.
13. Kashiwagi H, Spigelman AD. Gastroduodenal lesions in familial adenomatous polyposis. Surg Today 2000;30:675-682.
14. Goedde TA, Rodriguez-Bigas MA, Herrera L, Petrelli NJ. Gastroduodenal polyps in familial adenomatous polyposis. Surg Oncol 1992;1:357-361.
15. Debinski HS, Spigelman AD, Hatfield A, Williams CB, Phillips RKS. Upper intestinal surveillance in familial adenomatous polyposis. Eur J Cancer 1995;31:1149-1153.
16. Bulow S, Alm T, Fausa O, Hultcrantz R, Jarvinen H, Vasen H, the DAF Project Group. Duodenal adenomatosis in familial adenomatous polyposis. Int J Colorectal Dis 1995;10:43-46.
17. Sawada T, Muto T. Role of upper gastrointestinal surveillance in patients with familial adenomatous polyposis. Gastrointest Endosc Clin North Am 1997;7:99-110.
18. Björk J, Akerbrant H, Iselius L, Bergman A, Engwall Y, Wahlstrom J, Martinsson T, Nordling M, Hultcrantz R. Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: Cumulative risks and APC gene mutations. Gastroentelology 2001;121:1127-1135.
19. Matsumoto T, Iida M, Nakamura S, Hizawa K, Yao T, Tsuneyoshi M, Fujishima M. Natural history of ampullary adenoma in familial adenomatous polyposis: Reconfirmation of benign nature during extended surveillance. Am J Gastroenterol 2000;95:1557-1562.
20. Burke CA, Beck GJ, Church JM, van Stolk RU. The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program. Gastrointest Endosc 1999;49:358-364.
21. Bertoni G, Sassatelli R, Nigrisoli E, Pennazio M, Tansini P, Arrigoni A, Ponz de Leon M, Rossini FP, Bedogni G. High prevalence of adenomas and microadenomas of the duodenal papilla and periampullary region in patients with familial adenomatous polyposis. Eur J Gastroenterol Hepatol 1996;8:1201-1206.
22. Groves CJ, Saunders BP, Spigelman AD, Phillips RSK, Duodenal cancer in patients with familial adenomatous polyposis (FAP): Results of a 10 year prospective study. Gut 2002;50:636-641.
23. Penna C, Phillips RKS, Tiret E, Spigelman AD. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: Experience of two European centres. Br J Surg 1993;80:1027-1029.
24. Heiskanan I, Kellokumpu I, Jarvinen H. Management of duodenal adenomas in 98 patients with familial adenomatous polyposis. Endoscopy 1999;31:412-416.
25. Kadmon M, Tandara A, Herfarth C. Duodenal adenomatosis in familial adenomatous polyposis coli. A review of the literature and results from the Heidelberg Register. Int J Colorect Dis 2001;16:63-75.
26. Soravia C, Berk T, Haber G, Cohen Z, Gallinger S. Management of advanced duodenal polyposis in familial adenomatous polyposis. J GASTROINTEST SURG 1997;1:474-478.
27. Richard CS, Berk T, Bapat BV, Haber G, Cohen Z, Gallinger S. Sulindac for periampullary polyps in FAP patients. Int J Colorect Dis 1997;12:14-18.
28. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trzaskos JM, Evans JF, Taketo MM. Suppression of intestinal polyposis in APC knockout mice by inhibition of cylooxygenase2 (COX-2). Cell 1996;87:803-809.
29. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, Su LK, Levin B. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenoma tous polyposis. N Engl J Med 2000;342:1946-1952.
30. Phillips RKS, Wallace MH, Lynch P, Hawk E, Gordon GB, Saunders B, Wakabayashi N, Shen Y, Zimmerman S, Godio L, Rodrigues-Bigas M, Li-Kuo Su, Sherman J, Kelloff G, Levin B, Steinbach G, The FAP Study Group. A randomised double blind placebo controlled study of celecoxib, a selective cyclooxygenase-2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut 2002;50:857-860.